Kalaris Therapeutics, Inc. Common Stock (KLRS)

$4.23 +1.2%

EARNINGS ANALYTICS

event_upcoming Next Earnings: 2026-08-07 HIGH CONFIDENCE

Kalaris Therapeutics, Inc. Common Stock (KLRS) has reported earnings 15 times since Aug 06, 2021. The stock moves an average of ±4.31% the day after reporting, closing higher 40.0% of the time. Its largest post-earnings gain was +14.38% (Nov 02, 2023) and its largest decline was -9.56% (Aug 13, 2025). The next earnings report is predicted for 2026-08-07 (high confidence).

Earnings Price Reaction

Scroll to zoom, drag to pan — click earnings dots for details

Beat Miss

Earnings Impact

Total Earnings

Avg Abs. Movement

±4.31%

Positive %

40.0%

Negative %

60.0%

Historical Earnings Statistics

Date	Timing	Open	High	Close	Volume	Movement %	SEC Filing
May 12, 2026	☀ PRE	$4.56	$4.83	$4.80	20,904	+1.05%	open_in_new
Mar 17, 2026	☀ PRE	$8.47	$8.60	$8.51	1,008	-3.13%	open_in_new
Nov 12, 2025	☀ PRE	$4.88	$5.04	$5.04	1,207	-0.79%	open_in_new
Aug 13, 2025	☀ PRE	$2.46	$2.50	$2.27	1,142	-9.56%	open_in_new
May 14, 2025	☀ PRE	$3.20	$3.61	$3.33	2,245	+1.83%	open_in_new
Nov 02, 2023	☀ PRE	$1.59	$1.75	$1.75	18,407	+14.38%	open_in_new
Aug 03, 2023	☀ PRE	$2.99	$3.00	$2.98	18,214	-1.65%	open_in_new
May 04, 2023	☀ PRE	$3.92	$4.31	$4.25	8,182	+10.39%	open_in_new
Feb 15, 2023	☀ PRE	$6.50	$6.54	$6.25	31,686	-4.87%	open_in_new
Nov 03, 2022	☀ PRE	$7.13	$7.43	$6.94	20,448	-1.42%	open_in_new
Aug 04, 2022	☀ PRE	$5.85	$6.54	$6.52	18,164	+12.41%	open_in_new
May 05, 2022	☀ PRE	$4.84	$5.09	$4.92	20,979	-0.71%	open_in_new
Feb 10, 2022	☀ PRE	$8.17	$9.04	$8.48	29,693	-0.59%	open_in_new
Nov 05, 2021	☀ PRE	$24.70	$25.01	$24.55	4,815	-0.53%	open_in_new
Aug 06, 2021	☀ PRE	$19.84	$20.54	$20.47	10,722	+1.29%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±4.31%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

SEC Filing Types

description SCHEDULE 13D/A

1 chevron_right

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
4	20260604	open_in_new SEC.gov
4	20260604	open_in_new SEC.gov
4	20260604	open_in_new SEC.gov
4	20260604	open_in_new SEC.gov
4	20260604	open_in_new SEC.gov
4	20260604	open_in_new SEC.gov
4	20260604	open_in_new SEC.gov
8-K	20260604	open_in_new SEC.gov
4	20260522	open_in_new SEC.gov
SCHEDULE 13D/A	20260522	open_in_new SEC.gov

Frequently asked about KLRS earnings

When does Kalaris Therapeutics, Inc. Common Stock report earnings next? expand_more

Kalaris Therapeutics, Inc. Common Stock (KLRS)'s next earnings date is predicted (high confidence) for 2026-08-07. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does KLRS stock move after earnings? expand_more

Over 15 reports, KLRS has moved an average of ±4.31% the session after earnings, closing higher 40.0% of the time.

What was KLRS's biggest post-earnings move? expand_more

KLRS's largest post-earnings gain on record was +14.38% on Nov 02, 2023, and its largest decline was -9.56% on Aug 13, 2025.

Where can I find Kalaris Therapeutics, Inc. Common Stock's SEC filings? expand_more

All of Kalaris Therapeutics, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.